Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. (Q33394575)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. |
scientific article |
Statements
1 reference
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75. (English)
1 reference
Susan M Perkins
1 reference
Noah M Hahn
1 reference
Walter M Stadler
1 reference
Robin T Zon
1 reference
David Waterhouse
1 reference
Joel Picus
1 reference
Sreenivasa Nattam
1 reference
Cynthia S Johnson
1 reference
Mary Jane Waddell
1 reference
Christopher J Sweeney
1 reference
Hoosier Oncology Group
1 reference
21 March 2011
1 reference
1 reference
29
1 reference
12
1 reference
1525-1530
1 reference
Identifiers
1 reference
1 reference